Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort

INTRODUCTION: Concerns about dolutegravir (DTG) tolerability in the real‐life setting have recently arisen. We aimed to estimate the risk of treatment discontinuation and virological failure of DTG‐based regimens from a large cohort of HIV‐infected individuals. METHODS: We performed a multicentre, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mondi, Annalisa, Cozzi‐Lepri, Alessandro, Tavelli, Alessandro, Rusconi, Stefano, Vichi, Francesca, Ceccherini‐Silberstein, Francesca, Calcagno, Andrea, De Luca, Andrea, Maggiolo, Franco, Marchetti, Giulia, Antinori, Andrea, d'Arminio Monforte, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340053/
https://www.ncbi.nlm.nih.gov/pubmed/30663278
http://dx.doi.org/10.1002/jia2.25227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340053/
https://www.ncbi.nlm.nih.gov/pubmed/30663278
http://dx.doi.org/10.1002/jia2.25227

Ejemplares similares